메뉴 건너뛰기




Volumn 44, Issue 1, 2004, Pages 48-58

Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

Author keywords

Bioavailability; COX 2; Cyclooxygenase; Etoricoxib; Pharmacokinetics; Renal impairment

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; PLASMA PROTEIN;

EID: 10744219874     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003260338     Document Type: Article
Times cited : (19)

References (21)
  • 1
    • 0035145462 scopus 로고    scopus 로고
    • Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2
    • Riendeau D, Percival MD, Brideau C, Charleson S, Dube D, Ethier D, et al: Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 2001;296:558-566.
    • (2001) J Pharmacol Exp Ther , vol.296 , pp. 558-566
    • Riendeau, D.1    Percival, M.D.2    Brideau, C.3    Charleson, S.4    Dube, D.5    Ethier, D.6
  • 2
    • 0003111606 scopus 로고    scopus 로고
    • The history of anti-inflammatory drugs and their mechanism of action
    • Bazan N, Botting J, Vane J (eds.). London: Kluwer Academic and William Harvey Press
    • Vane JR, Botting RM: The history of anti-inflammatory drugs and their mechanism of action, in: Bazan N, Botting J, Vane J (eds.), New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules. London: Kluwer Academic and William Harvey Press, 1996;1-12.
    • (1996) New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules , pp. 1-12
    • Vane, J.R.1    Botting, R.M.2
  • 3
    • 0029040041 scopus 로고
    • Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs
    • Smith WL, DeWitt DL: Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Sem Nephrol 1995;15:179-194.
    • (1995) Sem Nephrol , vol.15 , pp. 179-194
    • Smith, W.L.1    DeWitt, D.L.2
  • 4
    • 0031113915 scopus 로고    scopus 로고
    • COX-II inhibitors - A new generation of safer NSAIDs?
    • Donnelly MT, Hawkey CJ: COX-II inhibitors - a new generation of safer NSAIDs? Aliment Pharmacol Ther 1997;11:227-236.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 227-236
    • Donnelly, M.T.1    Hawkey, C.J.2
  • 5
    • 0030911815 scopus 로고    scopus 로고
    • Cyclooxygenase isoenzymes: How recent findings affect thinking about nonsteroidal anti-inflammatory drugs
    • Jouzeau J-Y, Terlain B, Abid A, Nedelec E, Netter P: Cyclooxygenase isoenzymes: how recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 1997;53:563-582.
    • (1997) Drugs , vol.53 , pp. 563-582
    • Jouzeau, J.-Y.1    Terlain, B.2    Abid, A.3    Nedelec, E.4    Netter, P.5
  • 6
    • 0027146692 scopus 로고
    • Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
    • Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994;90:11693-11697.
    • (1994) Proc Natl Acad Sci USA , vol.90 , pp. 11693-11697
    • Mitchell, J.A.1    Akarasereenont, P.2    Thiemermann, C.3    Flower, R.J.4    Vane, J.R.5
  • 7
    • 0034707105 scopus 로고    scopus 로고
    • Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
    • Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-1528.
    • (2000) N Engl J Med , vol.343 , pp. 1520-1528
    • Bombardier, C.1    Laine, L.2    Reicin, A.3    Shapiro, D.4    Burgos-Vargas, R.5    Davis, B.6
  • 8
    • 0033601079 scopus 로고    scopus 로고
    • Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
    • Langman MJ, Jensen DM, Watson DJ, Harper SE, Zhao PL, Quan H, et al: Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999;282:1929-1933.
    • (1999) JAMA , vol.282 , pp. 1929-1933
    • Langman, M.J.1    Jensen, D.M.2    Watson, D.J.3    Harper, S.E.4    Zhao, P.L.5    Quan, H.6
  • 9
    • 0346906525 scopus 로고    scopus 로고
    • Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers
    • Rodrigues AD, Halpin RA, Geer LA, Cui D, Woolf EJ, Matthews CZ, et al: Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. Drug Metab Dispos 2003;43:268-276.
    • (2003) Drug Metab Dispos , vol.43 , pp. 268-276
    • Rodrigues, A.D.1    Halpin, R.A.2    Geer, L.A.3    Cui, D.4    Woolf, E.J.5    Matthews, C.Z.6
  • 10
    • 0034836419 scopus 로고    scopus 로고
    • Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers
    • Agrawal NGB, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, et al: Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. J Clin Pharmacol 2001;41:1106-1110.
    • (2001) J Clin Pharmacol , vol.41 , pp. 1106-1110
    • Agrawal, N.G.B.1    Porras, A.G.2    Matthews, C.Z.3    Woolf, E.J.4    Miller, J.L.5    Mukhopadhyay, S.6
  • 11
    • 0037372154 scopus 로고    scopus 로고
    • Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man
    • Agrawal NGB, Porras AG, Matthews CZ, Rose MJ, Woolf EJ, Musser BJ, et al: Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. J Clin Pharmacol 2003;43:268-276.
    • (2003) J Clin Pharmacol , vol.43 , pp. 268-276
    • Agrawal, N.G.B.1    Porras, A.G.2    Matthews, C.Z.3    Rose, M.J.4    Woolf, E.J.5    Musser, B.J.6
  • 12
    • 0035946023 scopus 로고    scopus 로고
    • High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection
    • Matthews CZ, Woolf EJ, Lin L, Fang W, Hsieh J, Ha S, et al: High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection. J Chromatogr B 2001;751:237-246.
    • (2001) J Chromatogr B , vol.751 , pp. 237-246
    • Matthews, C.Z.1    Woolf, E.J.2    Lin, L.3    Fang, W.4    Hsieh, J.5    Ha, S.6
  • 13
    • 0000568066 scopus 로고
    • A simplex optimization program
    • Yeh KC, Remphrey K: A simplex optimization program. Pharm Res 1990;7:S244.
    • (1990) Pharm Res , vol.7
    • Yeh, K.C.1    Remphrey, K.2
  • 14
    • 0036733531 scopus 로고    scopus 로고
    • Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis
    • Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, et al: Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. Rheumatology 2002;41:1052-1061.
    • (2002) Rheumatology , vol.41 , pp. 1052-1061
    • Gottesdiener, K.1    Schnitzer, T.2    Fisher, C.3    Bockow, B.4    Markenson, J.5    Ko, A.6
  • 15
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 16
    • 0035938410 scopus 로고    scopus 로고
    • In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)
    • Chauret N, Yergey JA, Brideau C, Friesen RW, Mancini J, Riendeau D, et al: In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). Bioorg Med Chem Lett 2001;11:1059-1062.
    • (2001) Bioorg Med Chem Lett , vol.11 , pp. 1059-1062
    • Chauret, N.1    Yergey, J.A.2    Brideau, C.3    Friesen, R.W.4    Mancini, J.5    Riendeau, D.6
  • 17
    • 33751335393 scopus 로고    scopus 로고
    • Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
    • Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol Renal Physiol 1997;272:F460-F468.
    • (1997) Am J Physiol Renal Physiol , vol.272
    • Komhoff, M.1    Grone, H.J.2    Klein, T.3    Seyberth, H.W.4    Nusing, R.M.5
  • 18
    • 0031679914 scopus 로고    scopus 로고
    • Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
    • Khan KNM, Venturini CM, Bunch RT, Brassard JA, Koki AT, Morris DL, et al: Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol 1998;26:612-620.
    • (1998) Toxicol Pathol , vol.26 , pp. 612-620
    • Khan, K.N.M.1    Venturini, C.M.2    Bunch, R.T.3    Brassard, J.A.4    Koki, A.T.5    Morris, D.L.6
  • 20
    • 0036244685 scopus 로고    scopus 로고
    • A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents
    • Gertz BJ, Krupa D, Bolognese JA, Sperling RS, Reicin A: A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents. Curr Med Res Opin 2002;18:82-91.
    • (2002) Curr Med Res Opin , vol.18 , pp. 82-91
    • Gertz, B.J.1    Krupa, D.2    Bolognese, J.A.3    Sperling, R.S.4    Reicin, A.5
  • 21
    • 0029445164 scopus 로고
    • Renal complications associated with use of nonsteroidal anti-inflammatory agents
    • Palmer BF: Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Invest Med 1995;43:516-533.
    • (1995) J Invest Med , vol.43 , pp. 516-533
    • Palmer, B.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.